Izbicki J R, Hamilton S R, Wambach G, Harnisch E, Wilker D K, Dornschneider G, Eibl-Eibesfeldt B, Schweiberer L
Dept of Surgery, University of Munich, FR Germany.
Br J Cancer. 1990 Feb;61(2):235-40. doi: 10.1038/bjc.1990.44.
Epidemiological and experimental studies suggest that androgens influence colonic carcinogenesis. We investigated the effects of hormonal manipulations (surgical and chemical castration, hormone substitution) on colonic tumour development, tumour and mucosal histopathology, and epithelial proliferation in macroscopically normal colonic mucosa in male rats, after induction of chemical colon carcinogenesis by subcutaneous injections of azoxymethane (AOM). Chemical castration with cyproterone acetate, but not surgical castration, resulted in increased colonic tumorigenesis, which was accompanied by decreased crypt length, decreased number of cells per crypt, and increased crypt epithelial mitotic index in the right colon. Chemically castrated rats also had crypt hyperplasia and increased numbers of dysplastic foci in the left colon which were not seen with surgical castration. By contrast, rats given testosterone after surgical castration showed decreased colonic tumorigenesis with an increased proportion of tumours in the left colon and lower percentage of tumours with invasion. The grossly normal mucosa of the testosterone-substituted castrated rats showed decreased crypt length in the right colon similar to the other groups of castrated rats, but no significant increase in mitotic index. Our results suggest that the anti-androgenic progestin cyproterone is a potent enhancer of colonic tumorigenesis and epithelial proliferative abnormalities after AOM administration. Exogenous testosterone after castration alters tumour distribution and characteristics and suppresses epithelial proliferative abnormalities. Finally, androgen effects on the colonic mucosa are more prominent in the right than in the left colon, suggesting different influences of hormones on the epithelium of these anatomical sites.
流行病学和实验研究表明,雄激素会影响结肠癌的发生。我们通过皮下注射氧化偶氮甲烷(AOM)诱导雄性大鼠发生化学性结肠癌后,研究了激素处理(手术去势和化学去势、激素替代)对结肠肿瘤发生、肿瘤和黏膜组织病理学以及大体正常结肠黏膜上皮增殖的影响。醋酸环丙孕酮进行化学去势而非手术去势,会导致结肠肿瘤发生增加,同时伴有右半结肠隐窝长度缩短、每个隐窝的细胞数量减少以及隐窝上皮有丝分裂指数增加。化学去势的大鼠左半结肠还出现了隐窝增生和发育异常病灶数量增加的情况,而手术去势的大鼠未出现这些情况。相比之下,手术去势后给予睾酮的大鼠结肠肿瘤发生减少,左半结肠肿瘤比例增加,侵袭性肿瘤的百分比降低。睾酮替代的去势大鼠大体正常的黏膜显示右半结肠隐窝长度缩短,与其他去势大鼠组相似,但有丝分裂指数无显著增加。我们的结果表明,抗雄激素孕激素醋酸环丙孕酮是AOM给药后结肠肿瘤发生和上皮增殖异常的强效增强剂。去势后给予外源性睾酮会改变肿瘤分布和特征,并抑制上皮增殖异常。最后,雄激素对结肠黏膜的影响在右半结肠比左半结肠更明显,表明激素对这些解剖部位上皮的影响不同。